NCT01580969: A reported trial by University of Utah
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT01580969 |
|---|---|
| Title | A Phase 1b/2 Study of Repeat rAdiation, Minocycline, and Bevacizumab in Patients With Recurrent gliOma (RAMBO) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | July 6, 2012 |
| Completion date | Jan. 12, 2018 |
| Required reporting date | Jan. 12, 2019, midnight |
| Actual reporting date | Jan. 11, 2019 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |